October 25, 2016 10:12 AM ET


Company Overview of Seres Therapeutics, Inc.

Executive Profile

Richard N. Kender MBA

Director, Chairman of Audit Committee and Member of Compensation Committee, Seres Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 Board Members in 4 different organizations across 7 different industries.

See Board Relationships


Mr. Richard N. Kender, also known as Rich, MBA, served as a Senior Vice President of Business Development and Corporate Licensing at Merck & Co., Inc. Mr. Kender served as Senior Vice President of Business Development and Corporate Licensing at Merck from 2000 to 2013. During his career at Merck, he was actively involved in more than 100 transactions, including a number that greatly influenced the course of the company. He also held positions with Merck in corporate ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 617-945-9626
Fax: --

Board Members Memberships

Director, Chairman of Audit Committee and Member of Compensation Committee
Independent Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
Independent Director


Fairleigh Dickinson University
Villanova University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$27,500
Total Calculated Compensation$220,897

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Seres Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.